@article{b5212e3d6af84a61a4825b0aab1e7f80,
title = "The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)",
abstract = "Gadobenate dimeglumine (MultiHance) has higher r1 relaxivity than gadoterate meglumine (Dotarem) which may permit the use of lower doses for MR imaging applications. Our aim was to compare 0.1- and 0.05-mmol/kg body weight gadobenate with 0.1-mmol/kg body weight gadoterate for MR imaging assessment of brain tumors.",
keywords = "Benefits, Brain Tumor Imaging, Gadoterate Meglumine, High Relaxivity, The BENEFIT Study, Benefits, Brain Tumor Imaging, Gadoterate Meglumine, High Relaxivity, The BENEFIT Study",
author = "M. Vaneckova and M. Herman and Smith, {M. P.} and M. Mechl and Maravilla, {K. R.} and J. Weichet and Spampinato, {M. V.} and J. {\v Z}i{\v z}ka and Wippold, {F. J.} and Baima, {J. J.} and R. Babbel and E. B{\"u}ltmann and Huang, {R. Y.} and Buhk, {J. H.} and A. Bonaf{\'e} and Cesare Colosimo and S. Lui and Kirchin, {M. A.} and N. Shen and G. Pirovano and A. Spinazzi",
year = "2015",
doi = "10.3174/ajnr.A4468",
language = "English",
volume = "36",
pages = "1589--1598",
journal = "AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY",
issn = "0195-6108",
publisher = "American Society of Neuroradiology:2210 Midwest Road, Suite 850:Oak Brook, IL 60521:(630)574-0220",
}